08.09.2021 22:24:00

Azurity Pharmaceuticals, Inc. -- Moody's assigns B2 CFR to Azurity Pharmaceuticals on acquisition of Arbor; outlook stable

Rating Action: Moody's assigns B2 CFR to Azurity Pharmaceuticals on acquisition of Arbor; outlook stable
Read the full article at Moody's